Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 8:58AM CST Zacks Equity Research - ZACKS - Fri Feb 21, 8:58AM CST
Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS
AbbVie Declares Quarterly Dividend PR Newswire - Thu Feb 20, 12:14PM CST CMTX - Thu Feb 20, 12:14PM CST
The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share.
One of Your Stock Investments is Being Acquired: Now What? Tracey Ryniec - Zacks Investment Research - Thu Feb 20, 9:23AM CST Tracey Ryniec - ZACKS - Thu Feb 20, 9:23AM CST
One of your companies gets a buyout offer and the shares soar. There might be different strategies for traders and investors on what to do next.
Signs That Your Trading Will Ruin Your Retirement - February 20, 2020 Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 8:12AM CST Zacks Equity Research - ZACKS - Thu Feb 20, 8:12AM CST
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
Easy Investing Secrets to an Early Retirement - February 19, 2020 Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:10AM CST Zacks Equity Research - ZACKS - Wed Feb 19, 8:10AM CST
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments,...
AbbVie to Present at the Cowen 40th Annual Health Care Conference PR Newswire - Wed Feb 19, 7:00AM CST CMTX - Wed Feb 19, 7:00AM CST
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Cowen 40th Annual Health Care Conference on Wednesday, March 4, 2020. Michael Severino, M.D., vice chairman...
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue PR Newswire - Wed Feb 19, 5:00AM CST CMTX - Wed Feb 19, 5:00AM CST
In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of February 17, 2020 its issued share capital, excluding treasury shares, is comprised...
Myasthenia Gravis Treatment Market: Global Industry Analysis and Opportunity Assessment 2019-2025 Brandessence Market Research - Wed Feb 19, 3:33AM CST CMTX - Wed Feb 19, 3:33AM CST
Myasthenia Gravis Treatment Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate...
SHAREHOLDER ALERT: Monteverde & Associates PC Launches an Investigation of the Board of Directors and Officers of AbbVie Inc. - ABBV PR Newswire - Tue Feb 18, 4:03PM CST CMTX - Tue Feb 18, 4:03PM CST
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors...
ImmunoGen (IMGN) Q4 Earnings & Sales Beat, Shares Rally Zacks Equity Research - Zacks Investment Research - Mon Feb 17, 8:41AM CST Zacks Equity Research - ZACKS - Mon Feb 17, 8:41AM CST
ImmunoGen (IMGN) reports fourth-quarter results with earnings and revenues beating estimates.
SmarTrend Watching for Potential Rebound in Shares of Abbvie Inc After 1.11% Loss Comtex SmarTrend(R) - Fri Feb 14, 10:55AM CST CMTX - Fri Feb 14, 10:55AM CST
Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $94.17 to a high of $95.30. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $95.11 on...
The Keys to Successfully Timing the Markets - February 14, 2020 Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 8:22AM CST Zacks Equity Research - ZACKS - Fri Feb 14, 8:22AM CST
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails Kinjel Shah - Zacks Investment Research - Fri Feb 14, 8:12AM CST Kinjel Shah - ZACKS - Fri Feb 14, 8:12AM CST
AbbVie (ABBV) and Allergan (AGN) announce Q4 results.
AbbVie's SKYRIZI(TM) Now Listed on the Nova Scotia Formulary for the Treatment of Moderate to Severe Plaque Psoriasis CNW Group - Thu Feb 13, 5:00AM CST CMTX - Thu Feb 13, 5:00AM CST
AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company, announced today that Nova Scotia has listed SKYRIZITM (risankizumab) on its provincial formulary for the treatment...
The Zacks Analyst Blog Highlights: AbbVie, Accenture, TOTAL, Amazon.com and Intuit Zacks Equity Research - Zacks Investment Research - Wed Feb 12, 8:43AM CST Zacks Equity Research - ZACKS - Wed Feb 12, 8:43AM CST
The Zacks Analyst Blog Highlights: AbbVie, Accenture, TOTAL, Amazon.com and Intuit
Top Stock Research Reports for AbbVie, Accenture, TOTAL & Others Sheraz Mian - Zacks Investment Research - Tue Feb 11, 12:09PM CST Sheraz Mian - ZACKS - Tue Feb 11, 12:09PM CST
Top Stock Research Reports for AbbVie, Accenture, TOTAL & Others
How Trading Your Own Retirement Can Fleece Your Financial Future - February 11, 2020 Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 8:12AM CST Zacks Equity Research - ZACKS - Tue Feb 11, 8:12AM CST
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
Pediatric Brain Tumor Drug Market is Growing Continuously and Could Reach US$1,659.4 Million by 2023 PR Newswire - Tue Feb 11, 7:40AM CST CMTX - Tue Feb 11, 7:40AM CST
Pediatric brain tumors are abnormal growths that arise in the brain during childhood. Although brain tumors are rare overall, they are the most common solid tumor among children. What's important to remember...
WBIO.CN : 1.150 (+10.58%) AbbVie to Present at the SVB Leerink 9th Annual Global Healthcare Conference PR Newswire - Tue Feb 11, 7:00AM CST CMTX - Tue Feb 11, 7:00AM CST
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the SVB Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25. Michael Severino, M.D., vice...
Allergan (AGN) Surpasses Q4 Earnings and Sales Estimates Kinjel Shah - Zacks Investment Research - Mon Feb 10, 2:11PM CST Kinjel Shah - ZACKS - Mon Feb 10, 2:11PM CST
Botox, Juvederm fillers and Vraylar drive Allergan's (AGN) fourth-quarter sales, making up for loss of exclusivity on some brands and lower sales of eye drug, Restasis.
